Neurotech International Ltd
ASX:NTI
Neurotech International Ltd
Revenue
Neurotech International Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
160%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Revenue
AU$1.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
34%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Neurotech International Ltd's Revenue?
Revenue
1.3m
AUD
Based on the financial report for Dec 31, 2023, Neurotech International Ltd's Revenue amounts to 1.3m AUD.
What is Neurotech International Ltd's Revenue growth rate?
Revenue CAGR 5Y
39%
Over the last year, the Revenue growth was 204%. The average annual Revenue growth rates for Neurotech International Ltd have been 160% over the past three years , 39% over the past five years .